Back
Maze Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
MAZE
Maze Therapeutics
Last Price:
$16.19
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAZE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Maze Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.01 | Buy |
20-day SMA: | 12.74 | Buy |
50-day SMA: | 11.72 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 11 | Buy |
20-day EMA: | 6.04 | Buy |
50-day EMA: | 2.78 | Buy |
200-day EMA: | 0.75 | Buy |
Maze Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.8 | Buy |
Relative Strength Index (14 RSI): | 66.64 | Buy |
Chaikin Money Flow: | 60239 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.3 - 14.28) | Buy |
Bollinger Bands (100): | (9.23 - 12.87) | Buy |
Maze Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Maze Therapeutics Stock
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 15.74 while MAZE 8-day simple moving average is 14.01, which is a Buy signal.
-
The stock price of MAZE is 15.74 while Maze Therapeutics 20-day SMA is 12.74, which makes it a Buy.
-
Maze Therapeutics 50-day simple moving average is 11.72 while MAZE share price is 15.74, making it a Buy technically.
-
MAZE stock price is 15.74 and Maze Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Buy
55
Maze Therapeutics (MAZE)
is a Buy
Is Maze Therapeutics a Buy or a Sell?
-
Maze Therapeutics stock is rated a BuyThe current Maze Therapeutics [MAZE] share price is $15.74. The Score for MAZE is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Maze Therapeutics Stock Info
Market Cap:
693.4M
Price in USD:
15.74
Share Volume:
71.6K
Maze Therapeutics 52-Week Range
52-Week High:
17.00
52-Week Low:
6.71
Buy
55
Maze Therapeutics (MAZE)
is a Buy
Maze Therapeutics Share Price Forecast
-
What is the Maze Therapeutics stock price today?The Maze Therapeutics stock price is 15.74 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics is not overvalued.
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 15.74 while MAZE 8-day exponential moving average is 11.00, which is a Buy signal.
-
The stock price of MAZE is 15.74 while Maze Therapeutics 20-day EMA is 6.04, which makes it a Buy.
-
Maze Therapeutics 50-day exponential moving average is 2.78 while MAZE share price is 15.74, making it a Buy technically.
-
MAZE stock price is 15.74 and Maze Therapeutics 200-day simple moving average is 0.75, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics
Is Maze Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.07 per share, an increase this year of $16.03 per share, and an increase next year of $0.67 per share.
Technical Analysis of Maze Therapeutics
Should I short Maze Therapeutics stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is 3.8, suggesting Maze Therapeutics is a Buy
-
Maze Therapeutics Relative Strength Index (RSI) is 66.64, which suggest Maze Therapeutics is overbought
-
The Bollinger Bands (25) for Maze Therapeutics is (11.3 - 14.28), which suggest Maze Therapeutics is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics is (9.23 - 12.87), which suggest Maze Therapeutics is a Buy
* Maze Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.